+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Carbetocin Market by Product Type, End User, Application, Delivery Channel - Global Forecast 2025-2030- Product Image
Carbetocin Market by Product Type, End User, Application, Delivery Channel - Global Forecast 2025-2030- Product Image
Sale

Carbetocin Market by Product Type, End User, Application, Delivery Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010691
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Carbetocin Market grew from USD 195.46 million in 2023 to USD 211.76 million in 2024. It is expected to continue growing at a CAGR of 6.24%, reaching USD 298.67 million by 2030.

Carbetocin is a synthetic hormone analog used primarily in obstetrics to prevent postpartum hemorrhage by mimicking the natural hormone oxytocin, facilitating uterine contractions. Its scope encompasses application primarily in postpartum care, particularly following cesarean sections, due to its effective uterotonic properties. The necessity of Carbetocin lies in its ability to reduce maternal morbidity associated with postpartum hemorrhage, a leading cause of maternal mortality worldwide. Its end-use scope tends to focus on healthcare institutions, including hospitals and maternity clinics.

Market growth is driven by factors such as the rising rate of cesarean sections globally, increasing awareness of maternal health, and supportive regulatory frameworks promoting safer childbirth practices. Emerging markets, due to their improving healthcare infrastructure and increasing focus on maternal health, present substantial opportunities. Technological advancements in drug formulation and delivery methods, such as heat-stable Carbetocin, expand its accessibility and effectiveness, particularly in low-resource settings.

However, the market faces limitations such as high cost, potential side effects, and stringent regulatory requirements that might affect broader adoption. Competitive pressures from alternative uterotonic drugs like oxytocin and ergometrine also pose challenges. Despite these challenges, regions with significant cesarean delivery rates and concerted efforts in maternal health improvement, like parts of Asia-Pacific and Africa, hold potential for business expansion.

Innovation and research can target enhancing formulation to improve drug stability and exploring new delivery systems to enhance efficacy and patient compliance. Research initiatives focusing on extending the indication of Carbetocin to non-obstetric fields, such as investigating its effects on bleeding disorders, could broaden its market potential.

In summary, while the market for Carbetocin is promising due to its crucial role in maternal care, the need for innovative solutions to overcome existing challenges is essential. Businesses should strategically focus on expanding into emerging markets, leveraging technological advancements, and continually adapting to changing regulatory landscapes to seize growth opportunities.

Understanding Market Dynamics in the Carbetocin Market

The Carbetocin Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing demand for effective postpartum hemorrhage management solutions across global healthcare facilities
    • Rising awareness and healthcare expenditure on maternal health and safety among expecting mothers
    • Technological advancements in drug formulations and delivery systems enhancing the efficacy of carbetocin products
  • Market Restraints
    • High cost and limited reimbursement
  • Market Opportunities
    • Expanding carbetocin usage in preventing postpartum hemorrhage in developed countries
    • Increasing carbetocin applications in veterinary medicine for childbirth assistance
    • Rising demand for carbetocin in emerging markets due to improved healthcare infrastructure
  • Market Challenges
    • Stringent regulatory landscape and approval processes

Exploring Porter’s Five Forces for the Carbetocin Market

Porter’s Five Forces framework further strengthens the insights of the Carbetocin Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Carbetocin Market

External macro-environmental factors deeply influence the performance of the Carbetocin Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Carbetocin Market

The Carbetocin Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Carbetocin Market

The Carbetocin Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Carbetocin Market

The Carbetocin Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Carbetocin Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, AstraZeneca, Bayer, Eli Lilly, Endo International, Ferring Pharmaceuticals, Fresenius Kabi, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Mylan, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Sun Pharmaceutical, and Teva Pharmaceutical.

Market Segmentation & Coverage

This research report categorizes the Carbetocin Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Concentration
      • High Concentration
      • Low Concentration
    • Formulation
      • Lyophilized Powder
      • Solution
    • Injection Type
      • Multi-Dose Vials
      • Single-Dose Vials
  • End User
    • Clinics
      • Fertility Clinics
      • Outpatient Clinics
    • Hospitals
      • Emergency Departments
      • Maternity Wards
    • Research Institutions
  • Application
    • Gynecological Applications
      • Fertility Treatments
      • Menorrhagia Management
    • Obstetric Applications
      • Cesarean Section
      • Labor Induction
      • Postpartum Hemorrhage
  • Delivery Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for effective postpartum hemorrhage management solutions across global healthcare facilities
5.1.1.2. Rising awareness and healthcare expenditure on maternal health and safety among expecting mothers
5.1.1.3. Technological advancements in drug formulations and delivery systems enhancing the efficacy of carbetocin products
5.1.2. Restraints
5.1.2.1. High cost and limited reimbursement
5.1.3. Opportunities
5.1.3.1. Expanding carbetocin usage in preventing postpartum hemorrhage in developed countries
5.1.3.2. Increasing carbetocin applications in veterinary medicine for childbirth assistance
5.1.3.3. Rising demand for carbetocin in emerging markets due to improved healthcare infrastructure
5.1.4. Challenges
5.1.4.1. Stringent regulatory landscape and approval processes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Carbetocin Market, by Product Type
6.1. Introduction
6.2. Concentration
6.2.1. High Concentration
6.2.2. Low Concentration
6.3. Formulation
6.3.1. Lyophilized Powder
6.3.2. Solution
6.4. Injection Type
6.4.1. Multi-Dose Vials
6.4.2. Single-Dose Vials
7. Carbetocin Market, by End User
7.1. Introduction
7.2. Clinics
7.2.1. Fertility Clinics
7.2.2. Outpatient Clinics
7.3. Hospitals
7.3.1. Emergency Departments
7.3.2. Maternity Wards
7.4. Research Institutions
8. Carbetocin Market, by Application
8.1. Introduction
8.2. Gynecological Applications
8.2.1. Fertility Treatments
8.2.2. Menorrhagia Management
8.3. Obstetric Applications
8.3.1. Cesarean Section
8.3.2. Labor Induction
8.3.3. Postpartum Hemorrhage
9. Carbetocin Market, by Delivery Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Carbetocin Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Carbetocin Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Carbetocin Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CARBETOCIN MARKET RESEARCH PROCESS
FIGURE 2. CARBETOCIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARBETOCIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARBETOCIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARBETOCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CARBETOCIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CARBETOCIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CARBETOCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CARBETOCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CARBETOCIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CARBETOCIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CARBETOCIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CARBETOCIN MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CARBETOCIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARBETOCIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARBETOCIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARBETOCIN MARKET DYNAMICS
TABLE 7. GLOBAL CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARBETOCIN MARKET SIZE, BY CONCENTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARBETOCIN MARKET SIZE, BY HIGH CONCENTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARBETOCIN MARKET SIZE, BY LOW CONCENTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARBETOCIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARBETOCIN MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARBETOCIN MARKET SIZE, BY INJECTION TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARBETOCIN MARKET SIZE, BY MULTI-DOSE VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARBETOCIN MARKET SIZE, BY SINGLE-DOSE VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARBETOCIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARBETOCIN MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARBETOCIN MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARBETOCIN MARKET SIZE, BY EMERGENCY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARBETOCIN MARKET SIZE, BY MATERNITY WARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARBETOCIN MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARBETOCIN MARKET SIZE, BY FERTILITY TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARBETOCIN MARKET SIZE, BY MENORRHAGIA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARBETOCIN MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARBETOCIN MARKET SIZE, BY LABOR INDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARBETOCIN MARKET SIZE, BY POSTPARTUM HEMORRHAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARBETOCIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARBETOCIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARBETOCIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. CANADA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 82. CANADA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. CANADA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 84. CANADA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 85. CANADA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 87. CANADA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 88. CANADA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES CARBETOCIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. CHINA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. CHINA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 137. CHINA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. CHINA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 139. CHINA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. CHINA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 141. CHINA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. CHINA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. CHINA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 144. CHINA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 145. CHINA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. INDIA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. INDIA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 148. INDIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 149. INDIA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDIA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. INDIA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. INDIA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. INDIA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. INDIA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. INDIA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 156. INDIA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. JAPAN CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. JAPAN CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 170. JAPAN CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 171. JAPAN CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 172. JAPAN CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. JAPAN CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 174. JAPAN CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. JAPAN CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. JAPAN CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 177. JAPAN CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 178. JAPAN CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. PHILIPPINES CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. PHILIPPINES CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 192. PHILIPPINES CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. PHILIPPINES CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SINGAPORE CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SINGAPORE CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 203. SINGAPORE CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 204. SINGAPORE CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SOUTH KOREA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. SOUTH KOREA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 214. SOUTH KOREA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. TAIWAN CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. TAIWAN CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 225. TAIWAN CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. THAILAND CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. THAILAND CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 236. THAILAND CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 237. THAILAND CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 238. THAILAND CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. THAILAND CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 240. THAILAND CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. THAILAND CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. THAILAND CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 243. THAILAND CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 244. THAILAND CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. VIETNAM CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. VIETNAM CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 247. VIETNAM CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. VIETNAM CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA CARBETOCIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 268. DENMARK CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. DENMARK CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 270. DENMARK CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 271. DENMARK CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 272. DENMARK CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. DENMARK CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 275. DENMARK CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. DENMARK CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 277. DENMARK CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 278. DENMARK CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. EGYPT CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. EGYPT CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 281. EGYPT CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 282. EGYPT CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 283. EGYPT CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. EGYPT CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. EGYPT CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. EGYPT CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. EGYPT CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 288. EGYPT CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 289. EGYPT CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. FINLAND CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. FINLAND CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 292. FINLAND CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 293. FINLAND CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 294. FINLAND CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. FINLAND CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 296. FINLAND CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 297. FINLAND CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. FINLAND CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 299. FINLAND CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 300. FINLAND CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. FRANCE CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. FRANCE CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 303. FRANCE CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. FRANCE CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 305. FRANCE CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. FRANCE CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 307. FRANCE CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 308. FRANCE CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. FRANCE CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 310. FRANCE CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 311. FRANCE CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. GERMANY CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. GERMANY CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 314. GERMANY CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 315. GERMANY CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 316. GERMANY CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. GERMANY CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. GERMANY CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. GERMANY CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. GERMANY CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 321. GERMANY CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 322. GERMANY CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 333. ISRAEL CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. ITALY CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. ITALY CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 336. ITALY CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 337. ITALY CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 338. ITALY CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. ITALY CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 340. ITALY CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 341. ITALY CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 342. ITALY CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 343. ITALY CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 344. ITALY CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 347. NETHERLANDS CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 348. NETHERLANDS CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 349. NETHERLANDS CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 350. NETHERLANDS CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 351. NETHERLANDS CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 352. NETHERLANDS CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 353. NETHERLANDS CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 354. NETHERLANDS CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 355. NETHERLANDS CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 356. NIGERIA CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 357. NIGERIA CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 358. NIGERIA CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 359. NIGERIA CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 360. NIGERIA CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 361. NIGERIA CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 362. NIGERIA CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 363. NIGERIA CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 364. NIGERIA CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 365. NIGERIA CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 366. NIGERIA CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 367. NORWAY CARBETOCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 368. NORWAY CARBETOCIN MARKET SIZE, BY CONCENTRATION, 2018-2030 (USD MILLION)
TABLE 369. NORWAY CARBETOCIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 370. NORWAY CARBETOCIN MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 371. NORWAY CARBETOCIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 372. NORWAY CARBETOCIN MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 373. NORWAY CARBETOCIN MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 374. NORWAY CARBETOCIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 375. NORWAY CARBETOCIN MARKET SIZE, BY GYNECOLOGICAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 376. NORWAY CARBETOCIN MARKET SIZE, BY OBSTETRIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 377. NORWAY CARBETOCIN MARKET SIZE, BY DELIVERY CHANNEL, 2018-2030 (USD MILLION)
TABLE 378. P

Companies Mentioned

The leading players in the Carbetocin market, which are profiled in this report, include:
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Eli Lilly
  • Endo International
  • Ferring Pharmaceuticals
  • Fresenius Kabi
  • Gilead Sciences
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co.
  • Mylan
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
  • Sun Pharmaceutical
  • Teva Pharmaceutical

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 211.76 Million
Forecasted Market Value ( USD ) by 2030 $ 298.67 Million
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Carbetocin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Carbetocin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 87 Pages
  • Global
From
Dydrogesterone Market by Type, Application - Global Forecast 2025-2030 - Product Image

Dydrogesterone Market by Type, Application - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Endometriosis Treatment Market by Drug Type, Treatment Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Endometriosis Treatment Market by Drug Type, Treatment Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR With CDSS), Application (Drug-Drug Interactions), Delivery Mode, Component, Region, and Segment Forecasts, 2024-2030 - Product Image

Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR With CDSS), Application (Drug-Drug Interactions), Delivery Mode, Component, Region, and Segment Forecasts, 2024-2030

  • Report
  • 135 Pages
  • Global
From
Telemedicine Market Size, Share & Trends Analysis Report by Component (Products, Services), Modality, Application (Teleradiology, Telepsychiatry), Delivery Mode, Facility, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Telemedicine Market Size, Share & Trends Analysis Report by Component (Products, Services), Modality, Application (Teleradiology, Telepsychiatry), Delivery Mode, Facility, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From

About the Carbetocin Market

Carbetocin is a synthetic oxytocin analogue used in the treatment of postpartum haemorrhage (PPH). It is a drug used in the field of Sexual and Reproductive Health (SRH) and is administered intravenously or intramuscularly. Carbetocin is used to reduce the risk of PPH, a major cause of maternal mortality and morbidity. It is also used to reduce the need for additional uterotonics and to reduce the risk of uterine atony. Carbetocin has been shown to be more effective than oxytocin in preventing PPH and has fewer side effects. Carbetocin is available in many countries, including the United States, Canada, Australia, and the United Kingdom. It is approved for use in the treatment of PPH in the United States and Canada. Some companies in the Carbetocin market include Ferring Pharmaceuticals, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.